Voice, Dyspnea and Acute Respiratory Failure
Launched by ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS · Apr 15, 2022
Trial Information
Current as of June 04, 2025
Withdrawn
Keywords
ClinConnect Summary
In the conceptual framework describe in the "brief summary" section of this document, this observational longitudinal monocentric study will include consecutive patients admitted in a specialised respiratory medicine ward for acute respiratory episodes. Any such episode will be considered be it "de novo" or complicating an underlying chronic respiratory disease. Vocal recordings will be performed daily, and will be analysed according to standard in the fields. Clinical parameters will also be recorded daily (vital signs, treatment intensity, outcome -including requirement for treatment inte...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • patients hospitalised in the Pitié-Salpêtrière Pneumology Department with an acute respiratory illness (pneumonia of any cause, COVID pneumonia depending on the epidemic context, COPD decompensation, etc);
- • whose condition allows conversational exchanges with the nursing staff within the framework of usual care;
- • adults, not protected;
- • understand and speak French fluently;
- • affiliated to the social security system;
- • having read and understood the information leaflet;
- • do not object to the use of their data;
- Exclusion Criteria:
- • a clinical condition on admission that is too severe to allow the patient to answer the usual questions of the anamnestic and clinical examination
- • patients with uncorrected hearing problems
- • patients with neurological, otorhinolaryngological or psychiatric pathology
About Assistance Publique Hôpitaux De Paris
Assistance Publique - Hôpitaux de Paris (AP-HP) is a leading public hospital system in France, renowned for its commitment to healthcare excellence and innovative medical research. As a prominent clinical trial sponsor, AP-HP plays a pivotal role in advancing medical knowledge and improving patient care through rigorous scientific investigations across a wide range of therapeutic areas. With a focus on collaboration and interdisciplinary approaches, AP-HP leverages its extensive network of hospitals and expert clinicians to facilitate high-quality clinical trials that adhere to the highest ethical and regulatory standards, ultimately aiming to translate research findings into tangible health benefits for diverse patient populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Paris, , France
Patients applied
Trial Officials
Thomas SIMILOWSKI, MD, PhD
Principal Investigator
Assistance Publique - Hôpitaux de Paris
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials